Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer-Reference-Cited by-同舟云学术

Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer

Published:2020 Issue:2 Volume:12 Page:877-887
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Nie Huifang¹²³⁴⁵,Xie Xiaodong¹²³⁴⁵,Zhang Doudou¹²³⁴⁵,Zhou Yu¹²³⁴⁵,Li Bifei¹²³⁴⁵,Li Fengqiao¹²³⁴⁵,Li Feiyang¹²³⁴⁵,Cheng Yunlong¹²³⁴⁵,Mei Hao¹²³⁴⁵,Meng Huan⁶⁷⁸⁹¹⁰^ORCID,Jia Lee¹²³⁴⁵^ORCID

Affiliation:

1. Cancer Metastasis Alert and Prevention Center

2. College of Chemistry; Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy

3. Fuzhou University

4. Fuzhou

5. China

6. California NanoSystems Institute

7. University of California

8. Los Angeles

9. USA

10. Department of Medicine

Abstract

Engineered exosomes have become popular drug delivery carriers for cancer treatment. Systemic injection of organotropic exosome carrier leads to efficient targeting and efficacious anti-cancer outcome.

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Natural Science Foundation of Fujian Province

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2020/NR/C9NR09011H

Reference33 articles.

1. Biogenesis and secretion of exosomes